National and Kapodistrian University of Athens
Η επίδραση της απότομης διακοπής λήψης στατινών στην αστάθεια της αθηρωματικής πλάκας
Abstract
dc:descriptionAggresive lipid reduction by the administration of statins may reduce cardiovascular morbidity and mortality in patients with atherosclerosis. Statins action is not limited to the reduction of LDL cholesterol but also to their so-called pleiotropic actions. Atherosclerotic plaque instability is a concept that has been introduced recently in order to explain why some atherosclerotic plaques cause symptoms (eg, heart attacks or strokes), while some other plaques do not, despite resulting in the same or greater degree of stenosis. Characteristics of the unstable atherosclerotic plaque are high fat content, intra-plaque hemorrhage, proximity of the necrotic nucleus to the lumen, thin fibrous cap, presence of ulceration on its surface and high inflammatory activity. Statins help to stabilize the atherosclerotic plaque both through their hypolipidemic properties and through their antioxidant and anti-inflammatory actions. Maintaining these beneficial effects of statins obviously requires their continued and uninterrupted administration. However, many patients discontinue arbitrarily their treatment as soon as they find that the desired cholesterol levels have been achieved.The aim of this study is to evaluate the impact of atorvastatin discontinuation on the progression and stability of atherosclerotic plaques in a valid animal model of atherosclerosis.Materials & Methods: Seventy ApoE-/- male mice fed with high-fat diet (Harlan, Teklad, 88137), beginning at the age of 8 weeks, were randomly assigned into the following experimental groups: A) Long-term intervention groups: 1) ATL, received atorvastatin for 12 weeks, 2) CO-12W, control received vehicle for 12 weeks, 3) ATW-6W, received atorvastatin for 6 weeks which was withdrawn for another 6 weeks. B) Short-term intervention groups: 1) ATS received atorvastatin for 6 weeks, 2) CO-6W, control receiving vehicle for 6 weeks, 3) ATW-3D, ATW-7D, received atorvastatin for 6 weeks which was withdrawn for 3 days and 7 days, respectively. Daily dosage of atorvastatin was 20 mg/kg. Mice were sacrificed, and aortic samples were obtained for histological evaluation. Blood serum was stored in test tubes which were placed in a special freezer (-80 ° C) for biochemical analysis. Before the euthanasia of the animals, a blood sampling took place and immediately afterwards it was done for tissue and organs (aorta, liver, heart) for histological analysis. Three days prior to euthanasia, a glucose tolerance test was performed after 6-hour fasting by glucose intraperitoneal administration (2 g / kg body weight) and blood glucose levels of the experimental animals were measured at 0, 15, 30, 60, 90 and 120 min. Results: Long-term atorvastatin treatment (ATL) induced atherosclerosis regression and stabilization compared to control (p<0.05). Atorvastatin’s withdrawal was associated with acute (ATW-3D) reduction in connective tissue and collagen contents within plaques compared to ATS (p < 0.05). Those changes were almost restored after a while (ATW-7D) and started appearing again after longer cessation (ATW-6W). Moreover, atorvastatin withdrawal induced shortly (ATW-3D) a peak in inflammatory markers (macrophages, MCP-1, TNF-a) and matrix metalloproteinases (MMP-3, MMP-9) concentrations within plaques, which sustained but to a lesser extent along time (ATW-7D, ATW-6W).Conclusion: In conclusion, the uninterrupted atorvastatin administration attenuated atherosclerosis progression and enhanced plaque stability via the suppression of inflammatory potential within the aortic atherosclerotic lesions of hypercholesterolemic ApoE−/− mice. When atorvastatin therapy was suddenly ceased, its atheroprotective effect seemed to be revoked promptly, leading to acute plaque destabilization, independent of cholesterol levels changes. The acute release of inflammatory mediators within the atherosclerotic plaques after statin’s discontinuation may explain mechanistically the exaggerated and unfavourable alterations in plaque stability in the short-term period. After initial rebound response, those effects were slightly smoothed thereafter, leading eventually to a sustained plaque destabilization in the long term. Our findings are of clinical importance outlining the risk of adverse events in atherosclerotic patients who do not comply to continuous statins’ therapy.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2019
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Stasinopoulou, Marianna
- Στασινοπούλου, Μαριάννα
Subjects
dc:subject × 14Rights
dc:rights- Statement dc:rights
-
- BY_NC_ND
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/46059